SAM
AMPH icon

Smartleaf Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Smartleaf Asset Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.25K Buy
273
+14
+5% +$343 ﹤0.01% 2635
2025
Q4 		$6.99K Buy
259
+52
+25% +$1.34K ﹤0.01% 2552
2025
Q3 		$5.57K Buy
207
+16
+8% +$413 ﹤0.01% 2340
2025
Q2 		$4.41K Sell
191
-376
-66% -$9.33K ﹤0.01% 2092
2025
Q1 		$16.1K Sell
567
-148
-21% -$4.73K ﹤0.01% 1716
2024
Q4 		$26.3K Buy
715
+493
+222% +$22.5K ﹤0.01% 1494
2024
Q3 		$10.7K Buy
222
+122
+122% +$5.35K ﹤0.01% 1713
2024
Q2 		$4.04K Buy
+100
New +$4.14K ﹤0.01% 1900

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Smartleaf Asset Management's AMPH Position: Q1 2026 in Review

Smartleaf Asset Management increased its Amphastar Pharmaceuticals (AMPH) stake by 5.4% in Q1 2026, buying an estimated $343 and bringing the position to 273 shares worth $5.25K. The position accounts for ﹤0.01% of the portfolio, ranked #2635.

Smartleaf Asset Management first reported a position in AMPH in Q2 2024 and has held it in 8 quarters since. The position peaked at $26.3K in Q4 2024. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Smartleaf Asset Management held 273 shares of Amphastar Pharmaceuticals worth $5.25K as of Q1 2026.
  • Smartleaf Asset Management bought 14 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $343.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2635 holding.
  • Smartleaf Asset Management first reported a position in Amphastar Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • Smartleaf Asset Management's Amphastar Pharmaceuticals position peaked at $26.3K in Q4 2024.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.